We anticipate that future studies of CaM regulation will uncover novel mediators/regulators of CaN and CaMKII signalling and intracellular Ca2+ dynamics, which could potentially be exploited to enhance muscle performance and treat conditions such as obesity, type 2 diabetes, and muscular dystrophy. The gene discussed is NUP214; the disease is muscular dystrophy.